Fin reduction is a novel and unexpected teratogenic effect of amikacin-treated zebrafish embryos

Toxicology Mechanisms and Methods

Volumn 22, Issue 2, 2012, Pages 151-158

  Chen, Ying Hsin ^a,b   Tsai, I Ting ^c   Wen, Chi Chung ^c   Wang, Yun Hsin ^d   Cheng, Chien Chung ^e   Hu, Sheng Chuan ^a,f   Chen, Yau Hung ^c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAMKANG UNIVERSITY   (Taiwan)

^d KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^e NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^f BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Amikacin; Fin; Neuromast; Ototoxicity; Zebrafish

Indexed keywords

AMIKACIN; CYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EMBRYOTOXICITY; FIN (ORGAN); IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; MORPHOLOGY; NICK END LABELING; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; SURVIVAL RATE; TERATOGENICITY; ZEBRA FISH;

ABNORMALITIES, DRUG-INDUCED; AMIKACIN; ANIMAL FINS; ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, NONMAMMALIAN; ZEBRAFISH;

DANIO RERIO;

EID: 84862922488     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2011.610385     Document Type: Article

References (37)

1. Amacher DE, Schomaker SJ, Meyers LL. 1989. Selective membrane toxicity of aminoglycoside antibiotics in membrane vesicles isolated from proximal renal tubules of the rat. Biochem Pharmacol 38:3867-3872. (Pubitemid 19284039)
2. Aran JM, Chappert C, Dulon D, Erre JP, Aurousseau C. 1995. Uptake of amikacin by hair cells of the guinea pig cochlea and vestibule and ototoxicity: Comparison with gentamicin. Hear Res 82:179-183.
3. Begg EJ, Barclay ML. 1995. Aminoglycosides-50 years on. Br J Clin Pharmacol 39:597-603.
4. Berglund F, Flodh H, Lundborg P, Prame B, Sannerstedt R. 1984. Drug use during pregnancy and breast-feeding. A classifcation system for drug information. Acta Obstet Gynecol Scand Suppl 126:1-55.
5. Brion N, Barge J, Godefroy I, Dromer F, Dubois C, Contrepois A, Carbon C. 1984. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits. Antimicrob Agents Chemother 25:168-172. (Pubitemid 14182932)
6. Chang CH, Lin CP, Wang HZ. 1995. Cytotoxicity of intracameral injection drugs to corneal endothelium as evaluated by corneal endothelial cell culture. Cornea 14:71-76.
7. Chen YH, Lin YT, Lee GH. 2009a. Novel and unexpected functions of zebrafsh CCAAT box binding transcription factor (NF-Y) B subunit during cartilages development. Bone 44:777-784.
8. Chen YH, Wang YH, Yu TH, Wu HJ, Pai CW. 2009b. Transgenic zebrafsh line with over-expression of Hedgehog on the skin: A useful tool to screen Hedgehog-inhibiting compounds. Transgenic Res 18:855-864.
9. Chen YH, Wen CC, Lin CY, Chou CY, Yang ZS, Wang YH. 2011. UV-induced fn damage in zebrafsh as a system for evaluating the chemopreventive potential of broccoli and caulifower extracts. Toxicol Mech Methods 21:63-69.
10. Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC. 2008. Using the zebrafsh lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 9:178-190.
11. Daudet N, Vago P, Ripoll C, Humbert G, Pujol R, Lenoir M. 1998. Characterization of atypical cells in the juvenile rat organ of corti after aminoglycoside ototoxicity. J Comp Neurol 401:145-162. (Pubitemid 28481959)
12. Duf P. 2002. Antibiotic selection in obstetrics: Making cost-efective choices. Clin Obstet Gynecol 45:59-72.
13. Forge A, Schacht J. 2000. Aminoglycoside antibiotics. Audiol Neurootol 5:3-22. (Pubitemid 30093591)
14. Ji B, Lefrançois S, Robert J, Chaufour A, Trufot C, Jarlier V. 2006. In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifoxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrob Agents Chemother 50:1921-1926. (Pubitemid 43807506)
15. Kotecha B, Richardson GP. 1994. Ototoxicity in vitro: Efects of neomycin, gentamicin, dihydrostreptomycin, amikacin, spectinomycin, neamine, spermine and poly-l-lysine. Hear Res 73:173-184.
16. Lacy CF, Armstrong LL, Goldman MP, Lance LL (2010) Lexi-Comp Drug Information Handbook, 19th Edition. Hudson, OH.
17. Lass JH, Mack RJ, Imperia PS, Mallick K, Lazarus HM. 1989. An in vitro analysis of aminoglycoside corneal epithelial toxicity. Curr Eye Res 8:299-304. (Pubitemid 19079634)
18. Lerner SA, Seligsohn R, Matz GJ. 1977. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med 62:919-923. (Pubitemid 8131972)
19. Luft FC, Aronof GR, Evan AP, Connors BA. 1981. Te efect of aminoglycosides on glomerular endothelium: A comparative study. Res Commun Chem Pathol Pharmacol 34:89-95. (Pubitemid 12239887)
20. Martínez-Salgado C, López-Hernández FJ, López-Novoa JM. 2007. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 223:86-98. (Pubitemid 47211265)
21. McCracken GH Jr. 1986. Aminoglycoside toxicity in infants and children. Am J Med 80:172-178. (Pubitemid 16036784)
22. Murillo-Cuesta S, Contreras J, Cediel R, Varela-Nieto I. 2010. Comparison of diferent aminoglycoside antibiotic treatments to refne ototoxicity studies in adult mice. Lab Anim 44:124-131.
23. Pacifci GM. 2006. Placental transfer of antibiotics administered to the mother: A review. Int J Clin Pharmacol Ter 44:57-63.
24. Pai CW, Chen YH. 2010. Transgenic expression of prothymosin α on zebrafsh epidermal cells promotes proliferation and attenuates UVB-induced apoptosis. Transgenic Res 19:655-665.
25. Parietti C, Vago P, Humbert G, Lenoir M. 1998. Attempt at hair cell neodiferentiation in developing and adult amikacin intoxicated rat cochleae. Brain Res 813:57-66. (Pubitemid 29012517)
26. Peng HC, Wang YH, Wen CC, Wang WH, Cheng CC, Chen YH. 2010. Nephrotoxicity assessments of acetaminophen during zebrafsh embryogenesis. Comp Biochem Physiol C Toxicol Pharmacol 151:480-486.
27. Rankin LI, Luft FC, Yum MN, Isaacs LL. 1980. Comparative nephrotoxicities of dibekacin, amikacin, and gentamicin in a rat model. Antimicrob Agents Chemother 18:983-985. (Pubitemid 11183007)
28. Selimoglu E. 2007. Aminoglycoside-induced ototoxicity. Curr Pharm Des 13:119-126. (Pubitemid 46085303)
29. Schaad UB, Guenin K, Stefen C, Herschkowtiz N. 1988. Efects of antimicrobial agents used for therapy of CNS infections on dissociated brain cell cultures. Pediatr Res 24:367-372.
30. Siddiqi A, Khan DA, Khan FA, Razzaq A. 2009. Terapeutic drug monitoring of amikacin in preterm and term infants. Singapore Med J 50:486-489.
31. Taylor RR, Nevill G, Forge A. 2008. Rapid hair cell loss: A mouse model for cochlear lesions. J Assoc Res Otolaryngol 9:44-64.
32. Wang HZ, Chang CH, Lin CP, Tsai MC. 1996. Using MTT viability assay to test the cytotoxicity of antibiotics and steroid to cultured porcine corneal endothelial cells. J Ocul Pharmacol Ter 12:35-43.
33. Wang YH, Li CK, Lee GH, Tsay HJ, Tsai HJ, Chen YH. 2008. Inactivation of zebrafsh mrf4 leads to myofbril misalignment and motor axon growth disorganization. Dev Dyn 237:1043-1050.
34. Wang YH, Wen CC, Yang ZS, Cheng CC, Tsai JN, Ku CC, Wu HJ, Chen YH. 2009a. Development of a whole-organism model to screen new compounds for sun protection. Mar Biotechnol 11:419-429.
35. Wang YH, Cheng CC, Lee WJ, Chiou ML, Pai CW, Wen CC, Chen WL, Chen YH. 2009b. A novel phenotype-based approach for systematically screening antiproliferation metallodrugs. Chem Biol Interact 182:84-91.
36. Westerfeld M (1995) Te zebrafsh book. Tird edition. University of Oregon Press.
37. Wu WJ, Sha SH, Schacht J. 2002. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol 7:171-174. (Pubitemid 34621569)